Tuberculosis in special populations

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 29, Issue SUPPL. 1, 2011, Pages 20-25

  Santín Cerezales, Miguel ^a   Elorza, Enrique Navas ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Comorbidity; Immigration; Immunosupression; Tuberculosis

Indexed keywords

AMIKACIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ATAZANAVIR; ATAZANAVIR PLUS RITONAVIR; CAPREOMYCIN; DARUNAVIR PLUS RITONAVIR; EFAVIRENZ; ENFUVIRTIDE; ETHAMBUTOL; ETRAVIRINE; FOSAMPRENAVIR PLUS RITONAVIR; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; LOPINAVIR PLUS RITONAVIR; MARAVIROC; MOXIFLOXACIN; NEVIRAPINE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RALTEGRAVIR; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; RIFAPENTINE; STEROID; STREPTOMYCIN; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; AREA UNDER THE CURVE; ARTICLE; BREAST FEEDING; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EXCRETION; DRUG INHIBITION; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; EYE TOXICITY; FRAIL ELDERLY; GRAFT RECIPIENT; GRAFT REJECTION; HEMODIALYSIS; HIGH RISK PATIENT; HOSPITALIZED CHILD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; IMMIGRATION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOASSAY; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; LATENT TUBERCULOSIS; LIVER TOXICITY; MIXED INFECTION; MORBIDITY; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; PREGNANCY; SHORT COURSE THERAPY; STEROID THERAPY; SURGICAL PATIENT; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DISEASE SUSCEPTIBILITY; EMIGRANTS AND IMMIGRANTS; FEMALE; FRAIL ELDERLY; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; LATENT TUBERCULOSIS; LIVER DISEASES; MYCOBACTERIUM TUBERCULOSIS; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SPAIN; TRANSPLANTATION; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; VULNERABLE POPULATIONS;

EID: 79952951358     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(11)70014-3     Document Type: Article

References (76)

1. Targeted tuberculin testing and treatment of latent tuberculosis infection American Thoracic Society MMWR Recomm Rep 49 RR-6 2000 1 51
2. E.L. Corbett, C.J. Watt, N. Walker, D. Maher, B.G. Williams, and M.C. Raviglione The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Arch Intern Med 163 2003 1009 1021 (Pubitemid 36548927)
3. A. Guerrero, J. Cobo, J. Fortún, E. Navas, C. Quereda, and A. Asensio Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection Lancet 350 1997 1738 1742 (Pubitemid 28036673)
4. N.R. Gandhi, A. Moll, A.W. Sturm, R. Pawinski, T. Govender, and U. Lalloo Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa Lancet 368 2006 1575 1580 (Pubitemid 44780738)
5. M.D. Keiper, M. Beumont, A. Elshami, C.P. Langlotz, and W.T. Miller Jr CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection Chest 107 1995 74 80
6. D.C. Perlman, W.M. El-Sadr, E.T. Nelson, J.P. Matts, E.E. Telzak, and N. Salomon Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG) Clin Infect Dis 25 1997 242 246 (Pubitemid 27364721)
7. A.M. Baciewicz, C.R. Chrisman, C.K. Finch, and T.H. Self Update on rifampin and rifabutin drug interactions Am J Med Sci 335 2008 126 136 (Pubitemid 351253409)
8. W.M. El-Sadr, and S.J. Tsiouris HIV-associated tuberculosis: diagnostic and treatment challenges Semin Respir Crit Care Med 29 2008 525 531
9. H.M. Blumberg, W.J. Burman, R.E. Chaisson, C.L. Daley, S.C. Etkind, and L.N. Friedman American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis Am J Respir Crit Care Med 167 2003 603 662
10. W. Burman, D. Benator, A. Vernon, A. Khan, B. Jones, and C. Silva Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis Am J Respir Crit Care Med 173 2006 350 356 (Pubitemid 43209091)
11. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors. MMWR Morb Mortal Wkly Rep. 2000;49:185-9.
12. H. McIlleron, G. Meintjes, W.J. Burman, and G. Maartens Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome J Infect Dis 196 Suppl 1 2007 S63 S75
13. S.S. Abdool Karim, K. Naidoo, A. Grobler, N. Padayatchi, C. Baxter, and A. Gray Timing of initiation of antiretroviral drugs during tuberculosis therapy N Engl J Med 362 2010 697 706
14. G. Meintjes, S.D. Lawn, F. Scano, G. Maartens, M.A. French, and W. Worodria Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings Lancet Infect Dis 8 2008 516 523 (Pubitemid 352005824)
15. M. Müller, S. Wandel, R. Colebunders, S. Attia, H. Furrer, and M. Egger Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis Lancet Infect Dis 10 2010 251 261
16. W.B. Park, P.G. Choe, J.H. Jo, S.H. Kim, J.H. Bang, and H.B. Kim Tuberculosis manifested by immune reconstitution inflammatory syndrome during HAART AIDS 21 2007 875 877 (Pubitemid 46573163)
17. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations Centers for Disease Control and Prevention MMWR Recomm Rep 47 RR-20 1998 1 58
18. Centers for Disease Control and Prevention Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents MMWR Early Release 58 2009 1 206
19. D.N. Rose Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost-effectiveness analysis Ann Intern Med 129 1998 779 786 (Pubitemid 28522812)
20. F. Gordin, R.E. Chaisson, J.P. Matts, C. Miller, and M. De Lourdes García Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group JAMA 283 2000 1445 1450
21. Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection - United States; 2003. MMWR Morb Mortal Wkly Rep. 2003;52:735-9.
22. P. Muñoz, C. Rodríguez, and E. Bouza Mycobacterium tuberculosis infection in recipients of solid organ transplants Clin Infect Dis 40 2005 581 587 (Pubitemid 40270229)
23. J. Torre-Cisneros, A. Doblas, J.M. Aguado, R. San Juan, M. Blanes, and M. Montejo Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort Clin Infect Dis 48 2009 1657 1665
24. P. Muñoz, J. Palomo, R. Muñoz, M. Rodríguez- Creixéms, T. Peláez, and E. Bouza Tuberculosis in heart transplant recipients Clin Infect Dis 21 1995 398 402
25. European best practice guidelines for renal transplantation Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis Nephrol Dial Transplant 17 Suppl 4 2002 39 43
26. J.M. Aguado, J. Torre-Cisneros, J. Fortún, N. Benito, Y. Meije, and A. Doblas Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology Clin Infect Dis 48 2009 1276 1284
27. H. Dunlop Infliximab (Remicade) and etanercept (Enbrel): serious infections and tuberculosis CMAJ 171 2004 992 993
28. J. Keane, S. Gershon, R.P. Wise, E. Mirabile-Levens, J. Kasznica, and W.D. Schwieterman Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 345 2001 1098 1104
29. K.L. Winthrop, and J.N. Siegel Tuberculosis cases associated with infliximab and etanercept Clin Infect Dis 39 2004 1256 1257 (Pubitemid 40169333)
30. L. Carmona, J.J. Gómez-Reino, V. Rodríguez-Valverde, D. Montero, E. Pascual-Gómez, E.M. Mola BIOBADASER Group Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists Arthritis Rheum 52 2005 1766 1772 (Pubitemid 40852885)
31. V. Rodríguez-Valverde, R. Cáliz, J.M. Álvaro-Gracia, J.L. Marenco de la Fuente, J. Mulero, and J. Tornero III Actualización del Consenso de la Sociedad Española de Reumatología sobre terapia biológica en la artritis reumatoide Reumatol Clin 2 Supl 2 2006 S52 S59
32. F. Bartalesi, S. Vicidomini, and D. Goletti QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases Eur Respir J 33 2009 586 593
33. A. Lalvani, and K.A. Millington Screening for tuberculosis infection prior to initiation of anti-TNF therapy Autoimmun Rev 8 2008 147 152
34. B.J. Marais, R.P. Gie, H.S. Schaaf, N. Beyers, P.R. Donald, and J.R. Starke Childhood pulmonary tuberculosis: old wisdom and new challenges Am J Respir Crit Care Med 173 2006 1078 1090 (Pubitemid 43726888)
35. H.S. Schaaf, B.J. Marais, A. Whitelaw, A.C. Hesseling, B. Eley, and G.D. Hussey Cultureconfirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases BMC Infect Dis 7 2007 140
36. B.J. Marais, C.C. Obihara, R.P. Gie, H.S. Schaaf, A.C. Hesseling, and C. Lombard The prevalence of symptoms associated with pulmonary tuberculosis in randomly selected children from a high burden community Arch Dis Child 90 2005 1166 1170 (Pubitemid 41565279)
37. L. Rigouts Clinical practice: diagnosis of childhood tuberculosis Eur J Pediatr 168 2009 1285 1290
38. M. Hatherill, T. Hawkridge, H.J. Zar, A. Whitelaw, M. Tameris, and L. Workman Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis? Arch Dis Child 94 2009 195 201
39. S.M. Graham, H.M. Daley, A. Banerjee, F.M. Salaniponi, and A.D. Harries Ethambutol in tuberculosis: time to reconsider? Arch Dis Child 79 1998 274 278 (Pubitemid 28420523)
40. S.M. Finnell, J.C. Christenson, and S.M. Downs Latent tuberculosis infection in children: a call for revised treatment guidelines Pediatrics 123 2009 816 822
41. R. Bindu, and N.W. Schluger Tuberculosis and pregnancy Semin Respir Crit Care Med 19 1998 295 306 (Pubitemid 28215287)
42. V.K. Arora, and R. Gupta Tuberculosis and pregnancy Ind J Tub 50 2003 13 16 (Pubitemid 36256684)
43. R. Figueroa-Damien, and J.L. Arredondo-García Pregnancy and tuberculosis: influence of treatment on perinatal outcome Am J Perinatol 15 1998 303 306 (Pubitemid 28257208)
44. K. Miller, and J.M. Miller Jr Tuberculosis in pregnancy: interactions, diagnosis, and management Clin Obstet Ginecol 39 1996 120 142 (Pubitemid 26060219)
45. E. Palacios, R. Dallman, M. Muñoz, R. Hurtado, K. Chalco, and D. Guerra Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in Lima, Peru Clin Infect Dis 48 2009 1413 1419
46. B.C. Brost, and R.B. Newman The maternal and fetal effects of tuberculosis therapy Obstet Gynecol Clin North Am 24 1997 659 673 (Pubitemid 27333111)
47. D.E. Snider, and K.E. Powell Should women taking antituberculosis drugs breast-feed? Arch Intern Med 144 1984 589 590 (Pubitemid 14152744)
48. T.T. Yoshikawa Tuberculosis and aging: a global health problem Clin Infect Dis 33 2001 1034 1039
49. W.W. Stead Special problems in tuberculosis: tuberculosis in the elderly and in residential homes, correctional facilities, long-term care hospitals, mental hospitals, shelters for the homeless, and jails Clin Chest Med 10 1989 397 405 (Pubitemid 19222976)
50. W. Stead, J. Lofgren, E. Warren, and C. Thomas Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes N Engl J Med 312 1985 1483 1487 (Pubitemid 15059234)
51. C. Pérez-Guzmán, M.H. Vargas, A. Torres-Cruz, and H. Villarreal-Velarde Does aging midify pulmonary tuberculosis? A meta-analytical review Chest 116 1999 961 967 (Pubitemid 29491866)
52. T. Vasankari, K. Liippo, and E. Tala Overt and cryptic miliary tuberculosis misdiagnosed until autopsy Scand J Infect Dis 35 2003 794 796 (Pubitemid 38028912)
53. R.B. Byrd, B.R. Horn, and D.A. Solomon Toxic effects of isoniazid in tuberculosis chemoprophylaxis: role of biochemical monitoring in 1,000 patients JAMA 241 1978 1239 1241 (Pubitemid 9222048)
54. K. Chmura, and E. Chan Tuberculosis in the elderly: keep a high index of suspicion J Respir Dis 27 2006 307 315 (Pubitemid 44618181)
55. J.N. Pande, S.P. Singh, G.C. Khilnani, S. Khilnani, and R.K. Tandon Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study Thorax 51 1996 132 136 (Pubitemid 26060649)
56. CDC Prevention and control of tuberculosis in facilities providing long-term care to the elderly. Recommendations of the advisory committee for elimination of tuberculosis MMWR 39 RR-10 1990 7 20
57. S. Chia, M. Karim, R.K. Elwood, and J.M. Fitzgerald Risk of tuberculosis in dialysis patients: a population-based study Int J Tuberc Lung Dis 2 1998 989 991 (Pubitemid 29005215)
58. R.S. Malone, D.N. Fish, D.M. Spiegel, J.M. Childs, and C.A. Peloquin The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol Am J Respir Crit Care Med 159 1999 1580 1584 (Pubitemid 29227873)
59. H. Stass, and D. Kubitza Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man J Antimicrob Chemother 43 1999 83 90 (Pubitemid 29231798)
60. M. Martínez-Lirola, N. Alonso-Rodríguez, M.L. Sánchez, M. Herranz, S. Andrés, and T. Peñafiel Advanced survey of tuberculosis transmission in a complex socioepidemiologic scenario with a high proportion of cases in immigrants Clin Infect Dis 47 2008 8 14 (Pubitemid 351920580)
61. O. Sanz-Peláez, J. Caminero-Luna, and L. Pérez-Arellano Tuberculosis e inmigración en España. Evidencias y controversias Med Clin (Barc) 126 2006 259 269
62. U.R. Dahle, P. Sandven, E. Heldal, and D.A. Caugant Continued low rates of transmission of Mycobacterium tuberculosis in Norway J Clin Microbiol 41 2003 2968 2973 (Pubitemid 36842286)
63. E. Geng, B. Kreiswirth, C. Driver, J. Li, J. Bruzynski, and P. DellaLatta Changes in the transmission of tuberculosis in New York City from 1900 to 1999 N Engl J Med 346 2002 1453 1458 (Pubitemid 34755713)
64. M. Ravins, H. Bercovier, D. Chemtob, Y. Fishman, and G. Rahav Molecular epidemiology of Mycobacterium tuberculosis infection in Israel J Clin Microbiol 39 2001 1175 1177 (Pubitemid 32209747)
65. S. Borrell, M. Español, A. Orcau, G. Tudó, F. March, and J.A. Cayl Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona Clin Microbiol Infect 2009 Epub ahead of print
66. S. Diz, R. López-Vélez, A. Moreno, J. Fortún, L. Moreno, and E. Gómez-Manpaso Epidemiology and clinical features of tuberculosis in immigrants at an infectious diseases department in Madrid Int J Tuberc Lung Dis 11 2007 769 774
67. J.M. Ramos, M. Masiá, J.C. Rodríguez, I. Padilla, M.J. Soler, and F. Gutiérrez Tuberculosis en inmigrantes: diferencias clínico-epidemiológicas con la población autóctona/1999-2002) Enferm Infecc Microbiol Clin 22 2004 315 318 (Pubitemid 38931534)
68. P.L. Zuber, M.T. McKenna, N.J. Bibkin, I.M. Onorato, and K.G. Castro Long-term risk of tuberculosis among foreign-born persons in the United States JAMA 278 1997 304 307 (Pubitemid 27339658)
69. K.P. Cain, C.A. Haley, L.R. Armstrong, K.N. Garman, C.D. Wells, and M.F. Iademarco Tuberculosis among foreign-born persons in the United States Am J Respir Crit Care Med 175 2007 75 79
70. A. Arce Arnáez, J. Iñigo Martínez, L. Cabello Ballesteros, and M. Burgoa Arenales Tuberculosis e inmigración en un área sanitaria de Madrid. Situación epidemiológica y evolución en la década 1994-2003 Med Clin (Barc) 125 2005 210 212
71. The WHO/IUATLD Global Project on anti-tuberculosis drug resistance surveillance. Four Global Report. Available at: http://www.who.int/tb/ publications/
72. H. Huerga, R. López-Vélez, E. Navas, and E. Gómez-Manpaso Clinicoepidemiological features of immigrants with tuberculosis living in Madrid, Spain Eur J Clin Microbiol Infect Dis 19 2000 236 237 (Pubitemid 30201304)
73. M. Tirado, R. Moreno, M. Marín, F. González, F. Pardo, and A. García del Busto Impact of immigration on drug resistance to Mycobacterium tuberculosis in Castellon (Spain): 1995-2003 Med Clin (Barc) 126 2006 761 764
74. J.A. Cayl, T. Rodrigo, J. Ruiz-Manzano, J.A. Caminero, R. Vidal, J.M. García Working Group on Completion of Tuberculosis Treatment in Spain (Study ECUTTE) Tuberculosis treatment adherence and fatality in Spain Respir Res 10 2009 121
75. L. Anibarro, S. Casas, J. Paz-Esquete, L. González, A. Pena, and M. Guerra and the Mycobacteria Study Group (GEIM) of Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).Treatment completion in latent tuberculosis infection at specialist tuberculosis units in Spain Int J Tuberc Lung Dis 14 2010 701 707
76. K. Dasgupta, and D. Menzies Cost-effectiveness of tuberculosis control strategies among immigrants and refugees Eur Respir J 25 2005 1107 1116 (Pubitemid 40823787)